NASDAQ: SEER
Seer Inc Stock

$2.28+0.00 (+0%)
Updated Feb 5, 2025
SEER Price
$2.28
Fair Value Price
N/A
Market Cap
$134.44M
52 Week Low
$1.51
52 Week High
$2.63
P/E
-1.75x
P/B
0.39x
P/S
8.25x
PEG
N/A
Dividend Yield
N/A
Revenue
$14.61M
Earnings
-$82.66M
Gross Margin
48.1%
Operating Margin
-565.83%
Profit Margin
-565.8%
Debt to Equity
0.11
Operating Cash Flow
-$45M
Beta
2.15
Next Earnings
Feb 26, 2025
Ex-Dividend
N/A
Next Dividend
N/A

SEER Overview

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine SEER's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

D
Value
C
Growth
C
Momentum
C
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
SEER
Ranked
#151 of 558

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important SEER news, forecast changes, insider trades & much more!

SEER News

Overview

Due Diligence Score

Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SEER scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SEER is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SEER is good value based on its book value relative to its share price (0.39x), compared to the US Biotechnology industry average (5.04x)
P/B vs Industry Valuation
SEER is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SEER due diligence checks available for Premium users.

Valuation

SEER price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-1.75x
Industry
-153.98x
Market
31.5x

SEER price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.39x
Industry
5.04x
SEER is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SEER's financial health

Profit margin

Revenue
$4.0M
Net Income
-$21.3M
Profit Margin
-529%
SEER's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
SEER's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$383.4M
Liabilities
$38.7M
Debt to equity
0.11
SEER's short-term assets ($264.10M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SEER's short-term assets ($264.10M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SEER's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$14.1M
Investing
$26.4M
Financing
-$6.6M
SEER's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SEER vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
SEERC$134.44M0.00%-1.75x0.39x
LCTXC$134.07M+7.58%-6.45x2.03x
MCRBC$134.88M-1.99%-3.43x5.64x
IVA$133.03M+2.92%-1.11x-1.51x
CRBUD$132.21M+4.29%-0.88x0.47x

Seer Stock FAQ

What is Seer's quote symbol?

(NASDAQ: SEER) Seer trades on the NASDAQ under the ticker symbol SEER. Seer stock quotes can also be displayed as NASDAQ: SEER.

If you're new to stock investing, here's how to buy Seer stock.

What is the 52 week high and low for Seer (NASDAQ: SEER)?

(NASDAQ: SEER) Seer's 52-week high was $2.63, and its 52-week low was $1.51. It is currently -13.14% from its 52-week high and 50.99% from its 52-week low.

How much is Seer stock worth today?

(NASDAQ: SEER) Seer currently has 58,966,560 outstanding shares. With Seer stock trading at $2.28 per share, the total value of Seer stock (market capitalization) is $134.44M.

Seer stock was originally listed at a price of $56.46 in Dec 4, 2020. If you had invested in Seer stock at $56.46, your return over the last 4 years would have been -95.96%, for an annualized return of -55.17% (not including any dividends or dividend reinvestments).

How much is Seer's stock price per share?

(NASDAQ: SEER) Seer stock price per share is $2.28 today (as of Feb 5, 2025).

What is Seer's Market Cap?

(NASDAQ: SEER) Seer's market cap is $134.44M, as of Feb 7, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Seer's market cap is calculated by multiplying SEER's current stock price of $2.28 by SEER's total outstanding shares of 58,966,560.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.